Caterina Fanello Selected Research

Sleep Initiation and Maintenance Disorders (Insomnia)

10/2007

A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Fanello Research Topics

Disease

10	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2023 - 10/2007
7	Malaria 10/2023 - 10/2007
5	Glucosephosphate Dehydrogenase Deficiency 10/2023 - 01/2018
2	Body Weight (Weight, Body) 01/2021 - 01/2018
1	Vomiting 01/2020
1	Hemolytic Anemia 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2007

Drug/Important Bio-Agent (IBA)

4	Primaquine FDA Link 10/2023 - 01/2018
3	ArtesunateIBA 12/2023 - 10/2007
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 10/2023 - 01/2023
2	artemisinin (artemisinine)IBA 01/2022 - 01/2020
2	Mefloquine (Lariam)FDA LinkGeneric 01/2020 - 10/2007
2	artenimol (dihydroartemisinin)IBA 01/2020 - 10/2007
2	piperaquineIBA 01/2020 - 10/2007
2	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2020 - 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 10/2023
1	Hemoglobins (Hemoglobin)IBA 10/2023
1	BilirubinIBA 10/2023
1	Sickle HemoglobinIBA 10/2023
1	hemozoinIBA 11/2022
1	AntigensIBA 01/2022
1	VaccinesIBA 01/2022
1	AntibodiesIBA 01/2022
1	Amodiaquine (Camoquin)FDA Link 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020

Therapy/Procedure

1	Therapeutics 01/2020